P. Hykin

776 total citations
20 papers, 556 citations indexed

About

P. Hykin is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Epidemiology. According to data from OpenAlex, P. Hykin has authored 20 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Ophthalmology, 10 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Epidemiology. Recurrent topics in P. Hykin's work include Retinal Diseases and Treatments (13 papers), Retinal and Optic Conditions (7 papers) and Retinal Imaging and Analysis (7 papers). P. Hykin is often cited by papers focused on Retinal Diseases and Treatments (13 papers), Retinal and Optic Conditions (7 papers) and Retinal Imaging and Analysis (7 papers). P. Hykin collaborates with scholars based in United Kingdom, India and Australia. P. Hykin's co-authors include Sobha Sivaprasad, Catey Bunce, Zdeněk Gregor, Clare Bailey, Winfried M. K. Amoaku, Jonathan Dowler, Sandra Rayner, W Xing, Peter Heyworth and M. A. Majid and has published in prestigious journals such as British Journal of Ophthalmology, British Medical Bulletin and Retina.

In The Last Decade

P. Hykin

19 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Hykin United Kingdom 13 492 357 51 47 29 20 556
Yuying Ji China 10 269 0.5× 131 0.4× 43 0.8× 26 0.6× 16 0.6× 36 334
René A. Cervantes-Castañeda United States 11 581 1.2× 141 0.4× 35 0.7× 50 1.1× 30 1.0× 16 679
Anthony Obeid United States 16 885 1.8× 631 1.8× 45 0.9× 44 0.9× 52 1.8× 68 954
Wuqaas M. Munir United States 12 297 0.6× 284 0.8× 33 0.6× 167 3.6× 28 1.0× 35 457
Mert Şimşek Türkiye 11 250 0.5× 120 0.3× 19 0.4× 53 1.1× 29 1.0× 33 315
Turner D. Wibbelsman United States 11 319 0.6× 234 0.7× 17 0.3× 20 0.4× 16 0.6× 31 362
Zaid Shalchi United Kingdom 15 416 0.8× 352 1.0× 49 1.0× 89 1.9× 49 1.7× 25 534
Maeve O’Doherty Ireland 10 211 0.4× 230 0.6× 15 0.3× 52 1.1× 85 2.9× 18 290
Lindsay Smithen United States 7 455 0.9× 201 0.6× 45 0.9× 34 0.7× 98 3.4× 14 527
Sylvia Nghiem‐Buffet France 15 624 1.3× 412 1.2× 45 0.9× 32 0.7× 32 1.1× 48 660

Countries citing papers authored by P. Hykin

Since Specialization
Citations

This map shows the geographic impact of P. Hykin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Hykin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Hykin more than expected).

Fields of papers citing papers by P. Hykin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Hykin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Hykin. The network helps show where P. Hykin may publish in the future.

Co-authorship network of co-authors of P. Hykin

This figure shows the co-authorship network connecting the top 25 collaborators of P. Hykin. A scholar is included among the top collaborators of P. Hykin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Hykin. P. Hykin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chandra, Shruti, Deepthy Menon, Hagar Khalid, et al.. (2020). Ten-year outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration. Eye. 34(10). 1888–1896. 64 indexed citations
2.
Flight, Laura, Abualbishr Alshreef, P. Hykin, et al.. (2019). PIN156 INTRAVITREAL THERAPY WITH RANIBIZUMAB VS AFLIBERCEPT VS BEVACIZUMAB FOR MACULAR OEDEMA DUE TO CENTRAL RETINAL VEIN OCCLUSION: A WITHIN TRIAL COST-UTILITY ANALYSIS. Value in Health. 22. S664–S664. 1 indexed citations
3.
4.
Schwartz, Roy, P. Hykin, & Sobha Sivaprasad. (2018). Localization of Paracentral Acute Middle Maculopathy Using Optical Coherence Tomography Angiography. Ophthalmic surgery, lasers & imaging retina. 49(8). 619–624. 2 indexed citations
5.
Schwartz, Roy, et al.. (2018). Normative Data on Foveal Avascular Zone Dimensions in Four Macular Vascular Layers. Ophthalmic surgery, lasers & imaging retina. 49(8). 580–586. 5 indexed citations
6.
Sivaprasad, Sobha, et al.. (2015). The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary. Eye. 29(12). 1633–1638. 55 indexed citations
7.
Ramu, Jayashree, Yit C. Yang, Geeta Menon, et al.. (2015). A randomized clinical trial comparing fixed vs pro-re-nata dosing of Ozurdex in refractory diabetic macular oedema (OZDRY study). Eye. 29(12). 1603–1612. 30 indexed citations
8.
Sivaprasad, Sobha & P. Hykin. (2013). What is new in the management of wet age-related macular degeneration?. British Medical Bulletin. 105(1). 201–211. 12 indexed citations
9.
Tufail, Adnan, Praveen J. Patel, Catherine Egan, et al.. (2010). Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study. BMJ. 340(jun09 4). c2459–c2459. 171 indexed citations
10.
Sivaprasad, Sobha, P. Hykin, Stephen Beatty, et al.. (2009). Intravitreal pegaptanib sodium for choroidal neovascularisation secondary to age-related macular degeneration: Pan-European experience. Eye. 24(5). 793–798. 9 indexed citations
11.
Kaines, Andrew, et al.. (2008). Diabetic Macular Oedema: A Prospective Randomised Trial of Management With Intravitreal Bevacizumab (avastin) versus Conventional Laser Therapy: A Description of Methodology. 49(13). 3505–3505. 1 indexed citations
12.
Patel, J I, et al.. (2005). Pars plana vitrectomy for diabetic macular oedema: OCT and functional correlations. Eye. 20(6). 674–680. 24 indexed citations
13.
Cree, I A, et al.. (2004). Angiopoietin-2 multiplies the permeability-enhancing effect of Vascular Endothelial Growth Factor on retinal endothelial cells. UCL Discovery (University College London). 1 indexed citations
14.
Zambarakji, Hadi, et al.. (2004). Vitrectomy and radial optic neurotomy for central retinal vein occlusion: effects on visual acuity and macular anatomy. Graefe s Archive for Clinical and Experimental Ophthalmology. 243(5). 397–405. 18 indexed citations
15.
Zachary, I, Usha Chakravarthy, George J. Allen, et al.. (2003). Correlation of Increased Vascular Endothelial Growth Factor With Neovascularization and Permeability in Ischemic Central Vein Occlusion.. Retina. 23(3). 432–433.
16.
Heyworth, Peter, et al.. (1998). Natural history of recurrent erosion syndrome---a 4 year review of 117 patients. British Journal of Ophthalmology. 82(1). 26–28. 59 indexed citations
17.
Okhravi, Narciss, H M A Towler, P. Hykin, Melville Matheson, & Susan Lightman. (1997). Assessment of a standard treatment protocol on visual outcome following presumed bacterial endophthalmitis. British Journal of Ophthalmology. 81(9). 719–725. 43 indexed citations
18.
19.
Onadim, Zerrin, P. Hykin, J L Hungerford, & John K. Cowell. (1991). Genetic counselling in retinoblastoma: importance of ocular fundus examination of first degree relatives and linkage analysis.. British Journal of Ophthalmology. 75(3). 147–150. 13 indexed citations
20.
Hykin, P., et al.. (1985). Pulmonary Mycobacterium tuberculosis in acquired immune deficiency syndrome.. BMJ. 291(6499). 849–850. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuying Ji Breakdown of academic impact, for papers by René A. Cervantes-Castañeda Breakdown of academic impact, for papers by Anthony Obeid Breakdown of academic impact, for papers by Wuqaas M. Munir Breakdown of academic impact, for papers by Mert Şimşek Breakdown of academic impact, for papers by Turner D. Wibbelsman Breakdown of academic impact, for papers by Zaid Shalchi Breakdown of academic impact, for papers by Maeve O’Doherty Breakdown of academic impact, for papers by Lindsay Smithen Breakdown of academic impact, for papers by Sylvia Nghiem‐Buffet
Rankless by CCL
2026